Sylvaine Artero Selected Research

Esapent

4/2021	Late-life cynical hostility is associated with white matter alterations and the risk of Alzheimer's disease.
11/2014	APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?
10/2012	Metabolic syndrome and localization of white matter hyperintensities in the elderly population.
8/2011	Suicidal behavior is associated with reduced corpus callosum area.
7/2010	Neurological signs and late-life depressive symptoms in a community population: the ESPRIT study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvaine Artero Research Topics

Disease

9	Dementia (Dementias) 04/2021 - 02/2006
5	Cognitive Dysfunction 11/2020 - 02/2006
4	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 01/2006
2	Stroke (Strokes) 01/2016 - 08/2010
1	Frailty 01/2022
1	Insulin Resistance 01/2022
1	Inflammation (Inflammations) 04/2019
1	Pain (Aches) 01/2017
1	Disorders of Excessive Somnolence (Hypersomnia) 03/2016
1	Ischemic Stroke 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2012
1	Chronic Disease (Chronic Diseases) 08/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2006
1	Vitamin E Deficiency 01/2006

Drug/Important Bio-Agent (IBA)

5	EsapentIBA 04/2021 - 07/2010
5	Pharmaceutical PreparationsIBA 08/2016 - 02/2006
3	ApolipoproteinsIBA 06/2022 - 01/2020
3	Apolipoprotein E4IBA 06/2022 - 01/2006
2	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2014
2	CarbohydratesIBA 01/2022 - 01/2020
2	Antihypertensive Agents (Antihypertensives)IBA 08/2016 - 01/2016
2	Cholinergic Antagonists (Anticholinergics)IBA 08/2010 - 02/2006
1	Amyloid (Amyloid Fibrils)IBA 06/2022
1	C-Reactive ProteinIBA 04/2019
1	Opioid Analgesics (Opioids)IBA 01/2017
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 08/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2016
1	Angiotensin Receptor AntagonistsIBA 01/2016
1	Apolipoproteins E (ApoE)IBA 11/2014
1	Caffeine (No Doz)FDA LinkGeneric 01/2010
1	Antidepressive Agents (Antidepressants)IBA 08/2009
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 02/2006
1	AntioxidantsIBA 01/2006
1	Vitamin E FDA LinkGeneric 01/2006

Therapy/Procedure

1	Therapeutics 01/2006